Jacintha Griffin - Site Lead for Technical Services, Operational Excellence & Innovation at Pfizer CentreOne explores how drug delivery methods have evolved to deliver complex formulations using multiparticulate technology - with a focus on extrusion-spheronisation coated bead technology.
Futuristic Pharma
A flexible delivery platform
The increasing complexity of molecules in the drug development pipeline calls for flexible and patient-centric drug delivery platforms.
Multiparticulate technology offers many advantages over conventional tabletting methods. These drug delivery systems provide the flexibility to design complex oral solid dosage (OSD) formulations that require controlled or extended release.